Format

Send to

Choose Destination
Ann Rheum Dis. 2019 Jan;78(1):131-139. doi: 10.1136/annrheumdis-2018-213518. Epub 2018 Oct 11.

In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy.

Author information

1
Normandie Univ, UNIROUEN, IRIB, Inserm, U1234, Departement of Immunology, Rouen University Hospital, Rouen, France.
2
Department of Internal Medicine and Clinical Immunology, Sorbonne Université, UPMC, Inserm, U974, Center of Research in Myology, Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France.
3
Normandie Univ, UNIROUEN, IRIB, CNRS, UMR6270, Rouen, France.
4
Normandie Univ, UNIROUEN, IRIB, EA 3830, Rouen, France.
5
Department of Research, Inova Diagnostics, San Diego, California, USA.
6
Normandie Univ, UNIROUEN, IRIB, Inserm, U1234, Departement of Immunology, Rouen University Hospital, Rouen, France olivier.boyer@chu-rouen.fr.
#
Contributed equally

Abstract

OBJECTIVES:

In autoimmunity, autoantibodies (aAb) may be simple biomarkers of disease or true pathogenic effectors. A form of idiopathic inflammatory myopathy associated with anti-signal recognition particle (SRP) or anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) aAb has been individualised and is referred to as immune-mediated necrotising myopathy (IMNM). The level of aAb correlates with IMNM activity and disease may respond to immunosuppression, suggesting that they are pathogenic. We aimed to evaluate the pathogenicity of IgG from patients with anti-SRP or anti-HMGCR aAb in vivo by developing the first mouse model of IMNM.

METHODS:

IgG from patients suffering from anti-SRP or anti-HMGCR associated IMNM were passively transferred to wild-type, Rag2-/- or complement C3-/- mice. Muscle deficiency was evaluated by muscle strength on electrostimulation and grip test. Histological analyses were performed after haematoxylin/eosin staining or by immunofluorescence or immunohistochemistry analysis. Antibody levels were quantified by addressable laser bead assay (ALBIA).

RESULTS:

Passive transfer of IgG from patients suffering from IMNM to C57BL/6 or Rag2-/- mice provoked muscle deficiency. Pathogenicity of aAb was reduced in C3-/- mice while increased by supplementation with human complement. Breakage of tolerance by active immunisation with SRP or HMGCR provoked disease.

CONCLUSION:

This study demonstrates that patient-derived anti-SRP+ and anti-HMGCR+ IgG are pathogenic towards muscle in vivo through a complement-mediated mechanism, definitively establishing the autoimmune character of IMNM. These data support the use of plasma exchanges and argue for evaluating complement-targeting therapies in IMNM.

KEYWORDS:

autoantibodies; autoimmune diseases; polymyositis

Conflict of interest statement

Competing interests: OBo is member of the Scientific Committee of CSL Behring Foundation (France) and received consulting fees from Inova Diagnostics.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center